Physician profile
Ross Bacon
NPI 1366528838
$599.49
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $94.55 · 2022: $118 · 2023: $112 · 2024: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $163.76 | 2022-2024 | |
| Mylan Specialty L.P. | $79.05 | 2019-2020 | |
| Grifols USA, LLC | $72.03 | 2023 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals Lp | $53.89 | 2020-2024 | Fasenra |
| Sunovion Pharmaceuticals INC. | $47.29 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $43.16 | 2023-2024 | Dupixent |
| Glaxosmithkline, LLC. | $42.55 | 2019-2022 | |
| Insmed, INC. | $16.24 | 2020 | |
| Pfizer INC. | $16.09 | 2022 | |
| Advanced Respiratory, INC | $15.29 | 2019 | |
| Mallinckrodt Enterprises LLC | $14.82 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.18 | 2019 | |
| Merck Sharp & Dohme LLC | $11.08 | 2019 | |
| United Therapeutics Corporation | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Bacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.